カレントテラピー　31-12　サンプル page 18/34

このページは カレントテラピー　31-12　サンプル の電子ブックに掲載されている18ページの概要です。
秒後に電子ブックの対象ページへ移動します。
「電子ブックを開く」をクリックすると今すぐ対象ページへ移動します。

概要：
カレントテラピー　31-12　サンプル

32 Current Therapy 2013 Vol.31 No.12122219999）Mittal RK, Bhargava V, Lal H, et al：Effect of esophagealcontraction on esophageal wall blood perfusion. Am J PhysiolGastrointest Liver Physiol 301：G1093-G1098, 201110）Nasr I, Attaluri A, Hashmi S, et al：Investigation of esophagealsensation and biomechanical properties in functionalchest pain. Neurogastroenterol Motil 22：520-526, e116, 201011）Kwiatek MA, Hirano I, Kahrilas PJ, et al：Mechanical propertiesof the esophagus in eosinophilic esophagitis. Gastroenterology140：82-90, 201112）Hershcovici T, Achem SR, Jha LK, et al：Systematicreview：the treatment of noncardiac chest pain. AlimentPharmacol Ther 35：5-14, 201213）Flook NW, Moayyedi P, Dent J, et al：Acid -suppressivetherapy with esomeprazole for relief of unexplained chestpain in primary care：a randomized, double-blind, placebocontrolledtrial. Am J Gastroenterol 108：56-64, 201314）Eherer AJ, Schwetz I, Hammer HF, et al：Effect of sildenafilon oesophageal motor function in healthy subjects andpatients with oesophageal motor disorders. Gut 50：758-764,200215）Vanuytsel T, Bisschops R, Farre R, et al：Botulinum toxinreduces Dysphagia in patients with nonachalasia primaryesophageal motility disorders. Clin Gastroenterol Hepatol11：1115-1121, e2, 201316）Rao SS, Mudipalli RS, Remes-Troche JM, et al：Theophyllineimproves esophageal chest pain ─ a randomized, placebo -controlled study. Am J Gastroenterol 102：930-938, 200717）Cannon RO 3rd, Quyyumi AA, Mincemoyer R, et al：Imipraminein patients with chest pain despite normal coronaryangiograms. N Engl J Med 330：1411-1417, 199418）Clouse RE, Lustman PJ, Eckert TC, et al：Low-dose trazodonefor symptomatic patients with esophageal contractionabnormalities. A double-blind, placebo-controlled trial. Gastroenterology92：1027-1036, 198719）Varia I, Logue E, O’Connor C, et al：Randomized trial of sertralinein patients with unexplained chest pain of noncardiacorigin. Am Heart J 140：367-372, 200020）Spinhoven P, Van der Does AJ, Van Dijk E, et al：Heartfocusedanxiety as a mediating variable in the treatment ofnoncardiac chest pain by cognitive-behavioral therapy andparoxetine. J Psychosom Res 69：227-235, 201021）Lee H, Kim JH, Min BH, et al：Efficacy of venlafaxine forsymptomatic relief in young adult patients with functionalchest pain：a randomized, double-blind, placebo-controlled,crossover trial. Am J Gastroenterol 105：1504-1512, 2010